Skip to main content
    S

    Septerna, Inc. Common Stock (SEPN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $41.67
    -0.93 (-2.18%)

    Market Cap: $2.03B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Septerna, Inc. Common Stock (SEPN) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Septerna, Inc. Common Stock (SEPN) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Septerna, Inc. Common Stock reported EPS of -$0.57, below the -$0.55 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    44%(4/9)
    Avg Surprise
    -103.25%

    Upcoming Estimates

    Reports Mar 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.46
    Range-$0.93 - -$0.21
    12 analysts
    Revenue Consensus
    $22.03M
    RangeN/A
    12 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.50
    Range-$0.50 - -$0.50
    1 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.31-63.9%
    60d ago-$0.37-35.1%
    30d ago-$0.37-35.1%
    7d ago-$0.37-35.1%
    Current-$0.50
    Revenue Consensus
    $11.05M
    RangeN/A
    2 analysts

    Next Report

    SEPN has an expected report date of Mar 8, 2027.

    Earnings History

    Of the 9 quarters below that had an estimate, SEPN beat 4 and missed 5. Revenue for the quarter ended Sep 30, 2026 was $18.88M, down 12.2% from $21.50M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.57-$0.55-$0.69 - -$0.24-3.64%MissN/A42 up, 1 downNov 9, 2026$18.88M
    Jun 30, 2026-$0.29-$0.48-$0.86 - -$0.16+39.58%BeatN/A51 up, 1 downAug 10, 2026$26.75M
    Mar 31, 2026-$0.19-$0.44-$0.57 - -$0.07+56.82%BeatN/A40 up, 2 downMay 12, 2026$26.52M
    Dec 31, 2025-$0.24-$0.72N/A+66.67%BeatN/A40 up, 1 downMar 9, 2026$24.12M
    Sep 30, 2025-$0.10$0.79-$0.40 - $3.80-112.66%MissN/A53 up, 0 downNov 10, 2025$21.50M
    Jun 30, 2025-$0.56$0.93-$0.46 - $4.00-160.22%MissN/A43 up, 0 downAug 11, 2025$119000
    Mar 31, 2025-$0.49-$0.38N/A-28.95%MissN/AN/AN/AMay 15, 2025$219000
    Dec 31, 2024-$0.64-$0.69N/A+6.80%BeatN/AN/AN/AMar 27, 2025$212000
    Sep 30, 2024-$8.40-$0.94N/A-793.62%MissN/AN/AN/ANov 7, 2024$176000
    Jun 30, 2024-$12.76N/AN/AN/AN/AN/AN/AN/AAug 28, 2024$370000
    Last 10 quarters

    Annual EPS

    Fiscal year endedEPSChange
    Sep 30, 2026-$1.05N/A
    Jun 30, 2026-$0.48N/A
    Dec 31, 2025-$1.39N/A
    Dec 31, 2024-$21.80N/A

    Frequently Asked Questions About SEPN

    When is Septerna, Inc. Common Stock's next earnings date?

    Septerna, Inc. Common Stock's next earnings report is expected for Mar 8, 2027.

    Did SEPN beat earnings estimates last quarter?

    No. Septerna, Inc. Common Stock reported EPS of -$0.57 for the quarter ended Sep 30, 2026, below the -$0.55 estimate by 3.64%.

    What EPS do analysts expect from SEPN next quarter?

    The consensus EPS estimate for Septerna, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.46 from 12 analysts, with estimates from -$0.93 to -$0.21.

    How often does SEPN beat earnings estimates?

    Septerna, Inc. Common Stock beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -16.95%.